Profit

Prefer Cadila Over Lupin, Sun Pharma: Jai Bala

PUBLISHED ON: March 30, 2016 | Duration: 4 min, 16 sec

  
loading..
Jai Bala of Cashthechaos.com says he believes focus should be on second rank pharma stocks like Cadila than front line names like Lupin and Sun Pharma. Second rank pharma companies are more likely to outperform the bigger players in terms of returns, he adds.
ALSO WATCH
Sensex Slides Over 1,000 Points As New Covid Variant Spooks Investors

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com